Next Article in Journal
Prognostic Significance of HER3 Expression in Patients with Cervical Cancer
Next Article in Special Issue
Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
Previous Article in Journal
Changing Landscape of Systemic Therapy in Biliary Tract Cancer
Previous Article in Special Issue
Neoadjuvant Pertuzumab Plus Trastuzumab in Combination with Docetaxel and Carboplatin in Patients with HER2-Positive Breast Cancer: Real-World Data from the National Institute of Oncology in Poland
 
 
Article

Article Versions Notes

Cancers 2022, 14(9), 2138; https://doi.org/10.3390/cancers14092138
Action Date Notes Link
article xml file uploaded 25 April 2022 10:28 CEST Original file -
article xml uploaded. 25 April 2022 10:28 CEST Update https://www.mdpi.com/2072-6694/14/9/2138/xml
article pdf uploaded. 25 April 2022 10:28 CEST Version of Record https://www.mdpi.com/2072-6694/14/9/2138/pdf
article html file updated 25 April 2022 10:30 CEST Original file -
article html file updated 2 August 2022 20:39 CEST Update https://www.mdpi.com/2072-6694/14/9/2138/html
Back to TopTop